Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy

Abstract

After a median follow-up of 6.5 months after cessation of therapy with oxaliplatin or taxanes, CIPN is common and leads to impairment in patient QoL. More research is needed to assess the impact of neurotoxicity on QoL.